For centuries, urolithiasis has been known for being one of the most painful diseases and its prevalence is increasing. 1 It is estimated that 8%-15% of people around the world would face renal colic some time in their lives. In total, urolithiasis has been diagnosed in about 12% of the US population, and every year, there are approximately 2 million treatment visits at outpatient clinics for the disease. 2 In the United States, renal colic accounts for 1% of all visits to the emergency department. However, for 50% of all patients with a history of renal calculi, this portion will rise to 50% after10 years. 1,3 Renal colic occurs as a result of spasm because of the obstruction and distension caused by calculus in the ureter. 1 As recommended by the European Association of Urology, non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are first-line treatments for renal colic. 4 However, they may cause renal injury by reducing renal blood circulation. 5,6 In addition, NSAIDs can cause gastrointestinal complications (such as ulcers and reflux). 7,8 Their use is also limited